BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6208998)

  • 1. Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis.
    Grant S; Bhalla K; Gleyzer M
    Cancer Res; 1984 Dec; 44(12 Pt 1):5505-10. PubMed ID: 6208998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and characterization of a deoxycytidine kinase-deficient human promyelocytic leukemic cell line highly resistant to 1-beta-D- arabinofuranosylcytosine.
    Bhalla K; Nayak R; Grant S
    Cancer Res; 1984 Nov; 44(11):5029-37. PubMed ID: 6091869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyrazofurin.
    Plagemann PG; Behrens M; Abraham D
    Cancer Res; 1978 Aug; 38(8):2458-66. PubMed ID: 78761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered 5-azacytidine metabolism following 3-deazauridine treatment of L5178Y and human myeloblasts.
    Grant S; Cadman E
    Cancer Res; 1980 Nov; 40(11):4000-6. PubMed ID: 6162541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in differentiation and pyrimidine pathway enzymes in 5-azacytidine resistant variants of a myoblast line.
    Ng SK; Rogers J; Sanwal BD
    J Cell Physiol; 1977 Feb; 90(2):361-47. PubMed ID: 65357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells.
    Grant S; Rauscher F; Jakubowski A; Cadman E
    Cancer Res; 1981 Feb; 41(2):410-8. PubMed ID: 6160908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uridylate-trapping sugar analogs in combination with inhibitors of uridylate synthesis de novo and 5-fluorouridine.
    Keppler D; Fauler J; Gasser T; Holstege A; Leube K; Schulz-Holstege C; Weckbecker G
    Adv Enzyme Regul; 1985; 23():61-79. PubMed ID: 2416194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of fluoropyrimidine-resistant murine leukemic cell lines by one-step mutation and selection.
    Mulkins MA; Heidelberger C
    Cancer Res; 1982 Mar; 42(3):956-64. PubMed ID: 6460554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uridine phosphorylase (-/-) murine embryonic stem cells clarify the key role of this enzyme in the regulation of the pyrimidine salvage pathway and in the activation of fluoropyrimidines.
    Cao D; Russell RL; Zhang D; Leffert JJ; Pizzorno G
    Cancer Res; 2002 Apr; 62(8):2313-7. PubMed ID: 11956089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity by 2,3-dihydro-1H-imidazolo[1,2-b]pyrazole in the human promyelocytic leukemic cell, HL-60.
    Grant S; Bhalla K; Rauscher F; Cadman E
    Cancer Res; 1983 Nov; 43(11):5093-100. PubMed ID: 6577943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uracil nucleotide synthesis in a human breast cancer cell line (MCF-7) and in two drug-resistant sublines that contain increased levels of enzymes of the de novo pyrimidine pathway.
    Karle JM; Cowan KH; Chisena CA; Cysyk RL
    Mol Pharmacol; 1986 Aug; 30(2):136-41. PubMed ID: 2874477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of action of the novel anticancer agent 6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarbo xylic acid sodium salt (NSC 368390): inhibition of de novo pyrimidine nucleotide biosynthesis.
    Chen SF; Ruben RL; Dexter DL
    Cancer Res; 1986 Oct; 46(10):5014-9. PubMed ID: 3019518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
    Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 3-deazauridine on the metabolism, toxicity, and antitumor activity of azacitidine in mice bearing L1210 leukemia sensitive and resistant to cytarabine.
    Li ZR; Campbell J; Rustum YM
    Cancer Treat Rep; 1983 Jun; 67(6):547-54. PubMed ID: 6190558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiles of pyrimidine biosynthesis, salvage and degradation in disks of potato (Solanum tuberosum L.) tubers.
    Katahira R; Ashihara H
    Planta; 2002 Sep; 215(5):821-8. PubMed ID: 12244448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of an anthracycline-resistant human leukemic cell line.
    Bhalla K; Hindenburg A; Taub RN; Grant S
    Cancer Res; 1985 Aug; 45(8):3657-62. PubMed ID: 3860286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of D-glucosamine and 6-azauridine on nucleotide contents, 5-fluorouridine uptake, and cytotoxicity in TA3 mammary tumor cells.
    Holstege A; Keppler D
    J Natl Cancer Inst; 1986 Mar; 76(3):485-92. PubMed ID: 2419623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pyrimidine antagonists on sialic acid regeneration in HL-60 cells.
    Hindenburg AA; Taub RN; Grant S; Chang G; Baker MA
    Cancer Res; 1985 Jul; 45(7):3048-52. PubMed ID: 3859365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biosynthesis of pyrimidine nucleotides in human leukemic cells.
    Sugiura Y; Fujioka S; Yoshida S
    Jpn J Cancer Res; 1986 Jul; 77(7):664-73. PubMed ID: 3091554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
    Voytek P; Beisler JA; Abbasi MM; Wolpert-DeFilippes MK
    Cancer Res; 1977 Jul; 37(7 Pt 1):1956-61. PubMed ID: 67884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.